MIG
ALDR

Mariner Investment Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Mariner Investment Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,800
Closed -$254K – 248
2015
Q2 		$254K Buy
+4,800
New +$175K 0.06% 162

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Mariner Investment Group's ALDR Position: Q3 2015 in Review

Mariner Investment Group sold out of Alder Biopharmaceuticals (ALDR) in Q3 2015, closing a stake of 4,800 shares — an estimated $254K sold.

Mariner Investment Group first reported a position in ALDR in Q2 2015 and held it in 1 quarter. The position peaked at $254K in Q2 2015. 140 funds tracked by Wall St. Rank hold ALDR as of Q3 2015.

  • Mariner Investment Group reported no remaining Alder Biopharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Mariner Investment Group sold 4,800 Alder Biopharmaceuticals shares in Q3 2015, an estimated $254K.
  • Mariner Investment Group first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Mariner Investment Group's Alder Biopharmaceuticals position peaked at $254K in Q2 2015.
  • 140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2015.

Based on Mariner Investment Group's 13F filing for Q3 2015, filed 6 Nov 2015.